SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-333618
Filing Date
2012-08-03
Accepted
2012-08-03 09:30:32
Documents
10
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d355772d10q.htm 10-Q 811883
2 CERTIFICATION OF THE CEO, UNDER RULE 13A-14(A), PURSUANT TO SECTION 302 d355772dex311.htm EX-31.1 6813
3 CERTIFICATION OF THE CFO, UNDER RULE 13A-14(A), PURSUANT TO SECTION 302 d355772dex312.htm EX-31.2 6784
4 CERTIFICATION OF THE CEO AND CFO, UNDER RULE 13A-14(A), PURSUANT TO SECTION 906 d355772dex32.htm EX-32 5559
  Complete submission text file 0001193125-12-333618.txt   7104772

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT wcrx-20120630.xml EX-101.INS 1108102
6 XBRL TAXONOMY EXTENSION SCHEMA wcrx-20120630.xsd EX-101.SCH 86870
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE wcrx-20120630_cal.xml EX-101.CAL 77103
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE wcrx-20120630_def.xml EX-101.DEF 381387
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE wcrx-20120630_lab.xml EX-101.LAB 534389
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wcrx-20120630_pre.xml EX-101.PRE 452093
Mailing Address 1 GRAND CANAL SQUARE DOCKLANDS, DUBLIN 2, IRELAND L2 00000
Business Address 1 GRAND CANAL SQUARE DOCKLANDS, DUBLIN 2, IRELAND L2 00000 353 1 897 2000
Warner Chilcott plc (Filer) CIK: 0001323854 (see all company filings)

IRS No.: 980626948 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-53772 | Film No.: 121005387
SIC: 2834 Pharmaceutical Preparations